Tyneside biotech start up 3D Bio Tissues is embarking on a US tour to drum up investor appetite on the back of advances in its lab grown meat products.
The Newcastle University spin-out, which is owned by London Stock Exchange-listed BSF Enterprise, says it will begin a roadshow at the end of the month, taking in the Future Food Tech Summit in New York - a meeting of scientists, manufacturers and food brands operating in the 'alternative protein' market. Having appointed a Boston-based PR and investor relations team to manage the process, the firm said it wants to improve its profile and increase liquidity in its shares.
The move follows BSF's listing on the over-the-counter OTCQB market - a decentralised market where companies, typically early stage firms, not listed on major exchanges are traded directly by a network of dealers. BSF describes it as one of the world's largest investment markets and has pledged to regularly engage with US investors.
